This resource serves as a guide to beginning medication assisted treatment for individuals with opioid use disorder or alcohol use disorder in the hospital setting. It is one of the protocols and tools developed for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program, which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder.
Search Results for: (118 results)
Provider Implementation Guide Using a Medication First Model
Source: Missouri Department of Mental Health Division of Behavioral Health
The Missouri Department of Mental Health (DMH) created this provider implementation guide for their Medication First opioid use disorder treatment model. The Medication First treatment model was developed by DMH staff with assistance from staff from the Missouri Institute of Mental Health at the University of Missouri, St. Louis, and is based on the successful Housing First model used to address homelessness.
Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder
Source: Mackey, K. et. al., Veterans Health Administration
A review of studies on barriers or facilitators to use of medication assisted treatment (MAT) for opioid use disorder (OUD) from the Veteran’s Health Administrations Evidence Synthesis Program. The use of MAT to treat OUD is an evidence-based practice that is often not implemented in real world settings.
Evidence-Based Practices and Medication Assisted Treatment for Opioid Use Disorder, Virginia Department of Medical Assistance Services
This 2019 bulletin describes evidence-based practices for providing medication assisted treatment (MAT) for individuals with opioid use disorder and coverage of these treatment by Virginia’s Medicaid program.
State Variations in Medicaid Prescriptions for Opioid Use Disorder from 2011 to 2018
Source: L. Clemons-Cope et. al.
This 2019 report from the Urban Institute analyzed Medicaid State Drug Utilization Data to assess variation in buprenorphine prescriptions across state Medicaid programs between 2011 and 2018.
Expanding Access to Burprenorphine in Primary Care Practices
Source: California Health Care Foundation
A one and a half hour webinar on best practices in expanding access to buprenorphine in primary care practices from the California Health Care Foundation. Funding Source: California Health Care Foundation
Support for Hospital Opioid Use Treatment (SHOUT)
Source: California Health Care Foundation
This website includes links to 7 webinars that make up the Support for Hospital Opioid Use Treatment (Project SHOUT) initiative of the California Health Care Foundation. Topics covered in the webinar series include: the case for inpatient opioid agonist therapy; buprenorphine and methadone induction; acute pain and
California Bridge Program
Source: Public Health Institute
The California Bridge Program works with hospitals and emergency departments in California to create programs to induct patients with opioid use disorder onto medication assisted treatment in the acute care setting and facilitate access to substance use disorder treatment by using treatment navigators. Their goal is to change the standard of care for treating
State Strategies for Expanding Access to Opioid Use Disorder Medications
Source: Center for Evidence-based Policy
This 2 page guide summarizes effective strategies to increase patient access to medication assisted treatment for opioid use disorder (OUD). Strategies for state program administrators, clinicians and health systems, and individuals with OUD are presented.
Medication-Assisted Treatment Options for Opioid Use Disorder (OUD)
Source: Center for Evidence-based Policy
This 2 page information guide explains the medication assisted treatment (MAT) options for treating opioid use disorder. Intended for patients and their caregivers, it includes information on MAT options, how they work, how to access the medications,, and additional information for patients to consider when selecting a MAT option with their health care provider. Funding Source: Consumer and Prescriber Education Grant Program, National Association of Attorney Generals